BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 30338790)

  • 1. MicroRNA-373-3p inhibits prostate cancer progression by targeting AKT1.
    Qu HW; Jin Y; Cui ZL; Jin XB
    Eur Rev Med Pharmacol Sci; 2018 Oct; 22(19):6252-6259. PubMed ID: 30338790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-520d-3p inhibits osteosarcoma progression by degradation of Akt1.
    He TD; Zhu JK; Wei ZX; Wang YM
    Eur Rev Med Pharmacol Sci; 2018 Apr; 22(8):2315-2320. PubMed ID: 29762834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-556-3p promotes the progression of esophageal cancer via targeting DAB2IP.
    Lu HB
    Eur Rev Med Pharmacol Sci; 2018 Oct; 22(20):6816-6823. PubMed ID: 30402845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MiR-506-3p acts as a novel tumor suppressor in prostate cancer through targeting GALNT4.
    Hu CY; You P; Zhang J; Zhang H; Jiang N
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5133-5138. PubMed ID: 31298366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Down-regulation of miR-605 promotes the proliferation and invasion of prostate cancer cells by up-regulating EN2.
    Zhou YJ; Yang HQ; Xia W; Cui L; Xu RF; Lu H; Xue Z; Zhang B; Tian ZN; Cao YJ; Xing ZY; Yin S; He XZ
    Life Sci; 2017 Dec; 190():7-14. PubMed ID: 28943214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-1236-3p inhibits proliferation and invasion of breast cancer cells by targeting ZEB1.
    Liang TC; Fu WG; Zhong YS
    Eur Rev Med Pharmacol Sci; 2019 Nov; 23(22):9988-9995. PubMed ID: 31799668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. microRNA-183-3p Inhibits Progression of Human Prostate Cancer by Downregulating High-Mobility Group Nucleosome Binding Domain 5.
    Li Y; He S; Zhan Y; He A; Gong Y; Ji G; Huang C; Peng D; Guan B; Li X; Zhou L
    DNA Cell Biol; 2019 Aug; 38(8):840-848. PubMed ID: 31314587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiR-605-3p inhibits malignant progression of prostate cancer by up-regulating EZH2.
    Pan MZ; Song YL; Gao F
    Eur Rev Med Pharmacol Sci; 2019 Oct; 23(20):8795-8805. PubMed ID: 31696466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-590-3p promotes cell proliferation and invasion by targeting inositol polyphosphate 4-phosphatase type II in human prostate cancer cells.
    Chen H; Luo Q; Li H
    Tumour Biol; 2017 Mar; 39(3):1010428317695941. PubMed ID: 28345464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-199b-3p suppresses malignant proliferation by targeting Phospholipase Cε and correlated with poor prognosis in prostate cancer.
    Liu J; Quan Z; Gao Y; Wu X; Zheng Y
    Biochem Biophys Res Commun; 2021 Oct; 576():73-79. PubMed ID: 34482026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-373-3p inhibits the growth of cervical cancer by targeting AKT1 both in vitro and in vivo.
    Yu MM; Wang GJ; Wu KH; Xue SL; Ju LL; Li QR; Xiong AW; Yin GP
    Acta Biochim Pol; 2021 Jul; 68(4):611-617. PubMed ID: 34236826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TATDN1 promotes the development and progression of breast cancer by targeting microRNA-140-3p.
    Yu XY; Tian JR; Yang D; Tan HR
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5293-5300. PubMed ID: 31298381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-212 participates in the development of prostate cancer by upregulating BMI1 via NF-κB pathway.
    Qu HW; Jin Y; Cui ZL; Jin XB
    Eur Rev Med Pharmacol Sci; 2018 Jun; 22(11):3348-3356. PubMed ID: 29917185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-140 inhibits proliferation and promotes apoptosis and cell cycle arrest of prostate cancer via degrading SOX4.
    Liu Y; Li F; Lai D; Xie Q; Yin Y; Yang M; Su Z
    J BUON; 2019; 24(1):249-255. PubMed ID: 30941977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-217 alleviates development of non-small cell lung cancer by inhibiting AKT3 via PI3K pathway.
    Qi YJ; Zha WJ; Zhang W
    Eur Rev Med Pharmacol Sci; 2018 Sep; 22(18):5972-5979. PubMed ID: 30280779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downregulation of miR-133a-3p promotes prostate cancer bone metastasis via activating PI3K/AKT signaling.
    Tang Y; Pan J; Huang S; Peng X; Zou X; Luo Y; Ren D; Zhang X; Li R; He P; Wa Q
    J Exp Clin Cancer Res; 2018 Jul; 37(1):160. PubMed ID: 30021600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. microRNA-205 and microRNA-338-3p Reduces Cell Apoptosis in Prostate Carcinoma Tissue and LNCaP Prostate Carcinoma Cells by Directly Targeting the B-Cell Lymphoma 2 (Bcl-2) Gene.
    Zhang X; Pan Y; Fu H; Zhang J
    Med Sci Monit; 2019 Feb; 25():1122-1132. PubMed ID: 30741252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-21 in peripheral blood mononuclear cells as a novel biomarker in the diagnosis and prognosis of prostate cancer.
    Yang B; Liu Z; Ning H; Zhang K; Pan D; Ding K; Huang W; Kang XL; Wang Y; Chen X
    Cancer Biomark; 2016 Jul; 17(2):223-30. PubMed ID: 27434290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-107 inhibits proliferation of prostate cancer cells by targeting cyclin E1.
    Zhang X; Jin K; Luo JD; Liu B; Xie LP
    Neoplasma; 2019 Sep; 66(5):704-716. PubMed ID: 31129966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-454-3p Is an Exosomal Biomarker and Functions as a Tumor Suppressor in Glioma.
    Shao N; Xue L; Wang R; Luo K; Zhi F; Lan Q
    Mol Cancer Ther; 2019 Feb; 18(2):459-469. PubMed ID: 30413650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.